A long way from becoming the ultimate primary diagnostic tool so hoped for.
I participated in the EN2 trial back in 2012 and I know of one other member of this group who also participated and in his case the result was a high level of EN2 in his urine and on a subsequent biopsy high-grade PINs were detected. He went on to have his prostate removed and as far as I can recall, the histology showed a low grade PCa.
In my case, no EN2 found however, 3 years later I was diagnosed with a Gleason 6 (3+3).
Once big pharma get involved as was the case with EN2, progress appears to stall, sometimes indefinitely.